Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1976-04-12
1977-08-02
Rosen, Sam
Drug, bio-affecting and body treating compositions
Lymphokine
424 88, 424 92, A61K 3912, A61K 3920, A61K 3900
Patent
active
040396576
ABSTRACT:
Sensitizing plasma protein is dissociated from antigen-plasma protein complex by agitating at low temperature under controlled pH.
REFERENCES:
patent: 2118117 (1938-05-01), Sevag
patent: 2506345 (1950-05-01), Cox et al.
patent: 3078215 (1963-02-01), Fantes et al.
patent: 3316153 (1967-04-01), Frank
McAleer William J.
Wasmuth Edward H.
Behan J. Jerome
Merck & Co. , Inc.
Perrella Donald J.
Rosen Sam
LandOfFree
Separating antigen from residual common sensitizing protein does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Separating antigen from residual common sensitizing protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Separating antigen from residual common sensitizing protein will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2299327